Algernon Pharmaceuticals Inc (AGNPF)

[tcm55]

It took 50M shares to start the IPF/CC Trial.
Money was hard to raise and the BTH technology is still on the shelf gathering dust. Yost took a copy and BLO benefited too. BTH shareholders paid. The same as with the Drug portfolio from NASH

Other PP deals paid for the South Korea COVID attempt and later the 'International' COVID CT.

""A relative reduction of cough count in these patients """is""" being viewed by the Company as encouraging news.""
It seems that their 'open label' Trial HAS produced enough "signal" to now seriously target CC.

The 'International' Trial has produced strong enough data for IL-6 to target Cancer Tumors. Supported now with Dartmoth data.

DMT microdosing for Stroke seems to be a well supported path with Dr Strassman and Dr Nutt.

Maybe with Dr Williams back, there may be some efforts directed toward advancing the NASH IBD or CKD drugs.

It's a speculative investment...
"knowledge is directly proportioned to learning from mistakes, if you make no mistakes you probably aren't doing anything.

I LIKE the new BOD and the efforts Algernon now have in work...GLTA...